February 11, 2012
| Bio-IT World > The Dark Side of Genomics


The Dark Side of Genomics


April 15, 2003 | Identifying genes is one of the more glamorous aspects of genomics, but it's difficult picking out the 1 percent to 2 percent of coding sequences amid all the nonsense and junk DNA.

Most genes undergo alternative splicing, producing two or more different proteins. Then, there are pseudogenes — genes that look functional but aren't. Some of these are "dead genes," according to University of California at Santa Cruz bioinformatician David Haussler. "They once had a function," he says, "but they have accumulated enough mutations to slowly decay and become worthless." Distinguishing functional genes from pseudogenes is not trivial.

Thanks in part to the mouse genome, completed last year (see Paper View, Feb. 2003 Bio·IT World), the emerging consensus is that the total number of human genes is less than the initial 30,000 estimate. But uncertainty remains, and Haussler concedes that "computational prediction of genes is simply very hard." New programs such as TwinScan from Washington University in St. Louis, and Genomix's EXP6, are assisting efforts to not only identify novel genes but also confirm the existence of "dark genes" — those predicted by computer programs but unverified by other techniques.

AnVil and Applied Biosystems (ABI) collaborated to shed light on the "dark" genome using PCR (polymerase chain reaction) methods with TaqMan, microarrays, and AnVil's advanced analytics, to study about 10,000 putative genes. AnVil designed the analytical program that "determines whether the lab data are hard evidence that these are genes," AnVil's John McCarthy says. Once "found again," those genes will help finalize the actual number of genes. ABI reports that 2,400 to 2,500 genes were confirmed after screening 9,500 predicted ones. Aside from the inherent scientific interest, "The assays for those genes will make a nice addition to our offering," ABI's Raymond Samaha says.

Ultimately, identifying all genes will be a walk in the park compared to what lies ahead. Eric Green of the National Human Genome Research Center says: "We will find all the genes. But we aren't even in diapers yet in terms of finding all the other stuff — the functionally important sequences and the regulatory elements."

—Malorye Branca

Back to Beyond the Blueprint 






White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 
Apply at http://jobs.tessella.com   

oxford nanopore logo 


Early Access Collaborations ManagersClick here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Click to  Apply  

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .